Kazumichi Abe

Fukushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Low body weight as a risk factor for serious azathioprine-related adverse events in patients with rheumatic diseases.

Low body weight as a risk factor for serious azathioprine-related adverse events in patients with rheumatic diseases.

Journal: Immunological medicine

Published: July 29, 2026

Marked Hyperbilirubinemia in a Patient with Intrahepatic Cholestasis of Pregnancy and a UGT1A1 Polymorphism: A Case Report.

Marked Hyperbilirubinemia in a Patient with Intrahepatic Cholestasis of Pregnancy and a UGT1A1 Polymorphism: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: July 05, 2026

Utility of pretreatment GLOBE score as a non-invasive prognostic tool in primary biliary cholangitis.

Utility of pretreatment GLOBE score as a non-invasive prognostic tool in primary biliary cholangitis.

Journal: Immunological medicine

Published: June 12, 2026

Response to "Comment on 'Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray'".

Response to "Comment on 'Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray'".

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 20, 2026

Emerging Serological Biomarkers for Autoimmune Hepatitis.

Emerging Serological Biomarkers for Autoimmune Hepatitis.

Journal: Journal of clinical medicine

Published: April 23, 2026

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 03, 2026

Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.

Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2026

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2026

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow-Up.

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow-Up.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 04, 2026

Novel autoantibodies in autoimmune hepatitis: from diagnostic challenges to molecular and spatial pathology.

Novel autoantibodies in autoimmune hepatitis: from diagnostic challenges to molecular and spatial pathology.

Journal: Medical molecular morphology

Published: February 25, 2026

Questionnaire-based nationwide survey on the safety of azathioprine in Japanese patients with rheumatic diseases: a cross-sectional study.

Questionnaire-based nationwide survey on the safety of azathioprine in Japanese patients with rheumatic diseases: a cross-sectional study.

Journal: Immunological medicine

Published: January 02, 2026

Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.

Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 23, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026